Institutional members access full text with Ovid®

Share this article on:

Healthcare-associated infections in the elderly: what's new

Katz, Morgan J.; Roghmann, Mary-Claire


The Financial Support and Sponsorship statement in the article, ‘Healthcare-associated infections in the elderly: what's new’ [1], which published in Volume 29 Issue 4, was missing information.

The correct Financial Support and Sponsorship should read as follows:

This work was supported by the National Institute of Health T32 AI007291-27 to MJK. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

The record is hereby corrected.

Current Opinion in Infectious Diseases. 30(4):448, August 2017.

Current Opinion in Infectious Diseases: August 2016 - Volume 29 - Issue 4 - p 388–393
doi: 10.1097/QCO.0000000000000283

Purpose of review The high-risk population and current lack of knowledge regarding appropriate infection prevention in the long-term care (LTC) setting has contributed to substantial rates of resistance and healthcare-associated infections in this arena. More evidence-based research on LTC is necessary, particularly now that the elderly population is increasing.

Recent findings Proposed government mandates highlight the urgent need to combat antimicrobial resistance in the LTC setting. Recent studies focusing on unique strategies for the prevention of transmission and infection with multidrug-resistant organisms in nursing homes are discussed, as well as attempts to formulate clear antimicrobial stewardship programs.

Summary The long-term setting has unique challenges to instituting effective infection control precautions, therefore current accepted methods used in acute-care facilities need to be modified. Recent data suggest that prevention of transmission in LTC may be achieved with focus on high-risk patients or specific care-based activities rather than colonization status. Antimicrobial stewardship and consultation with specialized physicians may be important measures to combat resistance and adverse events in LTC. The prevention of unnecessary antibiotic use in palliative care may reduce rates of resistance as well as discomfort for terminal patients.

aJohns Hopkins University, Department of Medicine, Division of Infectious Disease

bDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Geriatrics Research Education and Clinical Center, VA Maryland Healthcare System, Baltimore, Maryland, USA

Correspondence to Dr Morgan J. Katz, MD, Johns Hopkins University, Department of Medicine, Division of Infectious Disease, 1830 E Monument Street, Baltimore, MD 21287, USA. Tel: +1 410 245 1343; e-mail:

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.